论文部分内容阅读
目的:探讨肝蒂联合右肝静脉阻断在巨块型肝癌切除中的临床价值,降低患者死亡率。方法:选在我院就诊的120例巨块型肝癌患者,将其分为对照组和实验组,对照组患者行常规临床治疗,实验组患者行肝蒂联合右肝静脉阻断治疗,对比2组患者临床疗效。结果:实验组患者术中输血例数、术中出血量、手术时间和肝脏血流阻断时间等临床指标均显著优于对照组患者,2组患者临床疗效对比统计学差异明显(P<0.05)。结论:由本次临床研究结果可见,在巨块型肝癌切除中,应用肝蒂联合右肝静脉阻断,具有较为满意的临床疗效,因而临床应用价值较高。
Objective: To investigate the clinical value of hepatic pedicle combined right hepatic vein occlusion in the resection of giant-type liver cancer and to reduce the mortality rate. Methods: One hundred and twenty patients with giant liver cancer who were treated in our hospital were divided into control group and experimental group. Patients in control group underwent routine clinical treatment. Patients in experimental group were treated with hepatic pedicle and right hepatic vein occlusion, Group clinical efficacy. Results: The clinical indexes such as blood transfusion, blood loss, operation time and hepatic blood flow blocking time in the experimental group were significantly better than those in the control group. There was significant difference in the clinical curative effect between the two groups (P <0.05 ). Conclusion: From the results of this clinical study, it can be seen that in the resection of massive liver cancer, the application of hepatic pedicle and right hepatic vein occlusion has a satisfactory clinical effect and thus has a high clinical value.